首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP)
【2h】

Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP)

机译:心血管疾病患者的质量调整生命年(QALY)的货币价值:付费研究(WTP)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to estimate the monetary value of a QALY among patients with heart disease and to identify its determinants. A cross-sectional survey was conducted through face-to-face interview on 196 patients with cardiovascular disease from two heart hospitals in Tehran, Iran, to estimate the value of QALY using disaggregated and aggregated approaches. The EuroQol-5 Dimension (EQ-5D) questionnaire, Visual Analogue Scale (VAS), Time Trade-Off (TTO) and contingent valuation WTP techniques were employed, first to elicit patients’ preferences and then, to estimate WTP for QALY. The association of patients’ characteristics with WTP for QALY, was assessed through Heckman selection model. The Mean willingness to pay per QALY, estimated by the disaggregated approach ranged from 2,799 to 3599 US dollars. It is higher than the values, estimated from aggregated methods (USD 2,256 to 3,137). However, in both approaches, the values were less than one Gross Domestic Product (GDP) per capita of Iran. Significant variables were: Current health state, education, age, marital status, number of comorbidities, and household’s cost group. Our results challenge two major issues: the first, is a policy challenge which concerns the WHO recommendation to use less than 3 GDP per capita as a cost-effectiveness threshold value. The second, is an analytical challenge related to patients with zero QALY gain. More scrutiny is suggested on the issue of how patients with full health state valuation should be dealt with and what arbitrary value could be included in the estimation value of QALY when the disaggregated approach used.
机译:这项研究的目的是评估心脏病患者中QALY的货币价值,并确定其决定因素。通过面对面访谈,对伊朗德黑兰两家心脏病医院的196名心血管疾病患者进行了横断面调查,以采用分类和汇总方法估算QALY的价值。使用了EuroQol-5维度(EQ-5D)问卷,视觉模拟量表(VAS),时间权衡(TTO)和权变评估WTP技术,首先是要引起患者的喜好,然后才是估计QALY的WTP。通过Heckman选择模型评估了患者特征与QALY的WTP的关联。按分类方法估算,每QALY的平均支付意愿在2799美元至3599美元之间。它高于通过汇总方法估算的值(2,256美元至3,137美元)。但是,在这两种方法中,该值均低于伊朗的人均国内生产总值(GDP)。重要变量包括:当前的健康状况,教育程度,年龄,婚姻状况,合并症数和家庭的费用组。我们的结果挑战了两个主要问题:首先,是一项政策挑战,涉及世界卫生组织关于使用人均GDP低于3的成本效益阈值的建议。第二,是与QALY增益为零的患者相关的分析挑战。建议对如何处理具有完全健康状态评估的患者以及使用分解方法时QALY的估计值可以包括什么任意值的问题进行更多的审查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号